Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool October 9, 2008 Brian Orelli	Is Monsanto Back? Investors are giddy about Monsanto again. Should they be?
The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool March 23, 2006 Alyce Lomax	Monsanto: Monster Stock, or Just Plain Monster? Many things seem to be going right for Monsanto. However, what price are you willing to pay for growth? Are the profits worth the risks -- and the possible long-term ramifications -- for both investors and consumers?
The Motley Fool June 29, 2010 Brian Orelli	Foolish Forecast: Monsanto 2.0 With Monsanto's herbicide Roundup facing cheap generic competition, the agriculture giant has planted its hopes for growth solely in the field of biotech seeds.
The Motley Fool October 3, 2008 Brian Orelli	Guidance Up; Stock Price Down Agriculture investors remain wary.
The Motley Fool June 4, 2009 Brian Orelli	MegaMergers Going to the Dogs It looks like Merck isn't sure it'll be able to get its acquisition of Schering-Plough past regulators without doing a little trimming.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool October 10, 2007 Billy Fisher	Monsanto's Monster Year There's no doubt that 2007 has been a monster year for Monsanto, due to the craze over ethanol and corn, but will it last looking forward?
The Motley Fool March 26, 2008 Brian Orelli	Monsanto's Guidance Grows Like a Weed The company has had good reasons to set its sights higher. Can Monsanto's current upbeat news keep going strong?
The Motley Fool April 3, 2008 Brian Orelli	Monsanto's Planting Its Seeds Strong growth from the agricultural giant, but will it last?
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool September 17, 2010 Dave Mock	3 Reasons to Sell Monsanto Today Monsanto faces serious competitive threats on several fronts, threats that could continue to pressure the stock.
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool January 15, 2010 Brian Orelli	Monsanto Rounds Up Documents for the DOJ The government investigates the agriculture giant.
The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
The Motley Fool June 29, 2005 Stephen D. Simpson	Feast or Famine at Monsanto Disappointing guidance will hurt the agribusiness company's stock, but the business still seems quite good.
The Motley Fool April 4, 2006 Rich Smith	Foolish Forecast: Monsanto Still Growing Although the winter quarter isn't usually strong for agriculture, Monsanto's rolling numbers support its CEO's assessment of the business. Over the past 18 months, the company has managed to grow its gross margins 60 basis points. Investors, take note.
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool October 13, 2005 Brian Gorman	Monsanto's Abundant Harvest The agricultural technology giant's strong 2005 results demonstrate that business is on track. As for the future, the company now expects fiscal 2006 earnings to be between $2.35 and $2.50 per share, up from a June prediction of $2.34.
The Motley Fool January 8, 2009 Brian Orelli	Monsanto's Back! Monsanto blew the doors off Wall Street's estimates, and raised yearly guidance by 5% at the low end.
The Motley Fool January 18, 2007 Alyce Lomax	What's Missing at Starbucks? Starbucks switches to milk without artificial growth hormone; it seems that sometimes, an item's absence can be a competitive advantage.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
The Motley Fool October 15, 2010 Tim Hanson	Monsanto's Pain Is Syngenta's Gain Monsanto may be down, but Syngenta and others in the sector are on the upswing.
The Motley Fool January 3, 2006 Rich Smith	Foolish Forecast: Monsanto Ready to Bloom Expect a positive "earnings surprise" Wednesday -- but one that should come as a surprise to absolutely no one.
The Motley Fool June 26, 2007 Rich Duprey	Foolish Forecast: Monsanto's Monstrous Growth Agricultural products company Monsanto will report third-quarter 2007 financial results on Thursday. Will investors on the sidelines be green with envy?
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
The Motley Fool May 6, 2009 Brian Orelli	Monsanto Kills the Love Monsanto announces that it's suing DuPont over a claimed misuse of Monsanto's herbicide-tolerant Roundup Ready technology.
The Motley Fool July 15, 2010 Brian Orelli	Insider Buying at Monsanto Monsanto's CEO and CFO bought shares. Should you?
The Motley Fool March 14, 2011 Brian Orelli	This Deal Is No Dog Eli Lilly picks up Johnson & Johnson's European animal-health business.
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
The Motley Fool December 7, 2009 Jordan DiPietro	How Terrible Is Monsanto? Monsanto, the global provider of agricultural products, finds its reputation being slammed in a recent food documentary, Food Inc. Which is Monsanto -- savior or sinner?
The Motley Fool January 25, 2005 Brian Gorman	Monsanto Picks Seminis Monsanto's latest acquisition provides a sensible avenue for growth. Investors apparently are less than thrilled about the deal, because they sent the stock down almost 7% in trading.
The Motley Fool April 9, 2007 Ryan Fuhrmann	Scrutinizing Monsanto's Outlook Food for thought about what's driving Monsanto. Investors, in many respects, considering Monsanto is more akin to finding opportunities in biotechnology than looking into the heartland.
Chemistry World April 12, 2013 Anbdrew Turley	DuPont and Monsanto settle Roundup dispute Two US chemical heavyweights -- DuPont and agrichemical company Monsanto -- have agreed to drop a long running intellectual property dispute to make way for a series of licensing deals worth at least $1.75 billion.
The Motley Fool August 26, 2010 Jim Mueller	How Did You Manage That, Monsanto? Here's a look at the earning pattern of Monsanto, the seed and chemical company, over the past few years.
The Motley Fool January 6, 2011 Stoyan Bojinov	Thursday's ETF to Watch: Market Vectors Agribusiness ETF (MOO) Monsanto reports earnings today.
The Motley Fool March 23, 2011 Brian Orelli	Eli Lilly: Great Plan, Poor Execution Eli Lilly shuns large mergers, but hasn't produced drugs on its own.
The Motley Fool February 18, 2005 Brian Gorman	Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one.